01 November 1996
Recovery of forced vital capacity directly correlates with reversal of benzodiazepine-induced sedation
Avi A. Weinbroum, Valery Rudick, Patrick Sorkine, Pinhas Halpern, Ron Flaishon, David Niv, Eran GellerMed Sci Monit 1996; 2(6): CR756-763 :: ID: 500150
Abstract
Background: Benzodiazepines induce sedation and depress high mental functions and respiration. We conducted a prospective, randomized double-blind study on the efficacy of flumazenil in reversing the effects of these functions and the possible relationship between them.
Material/Methods:One hundred and six ASA II-III patients, aged 61±1.6 (SEM) (ranges 20-86) years were sedated intraoperatively with IV midazolam (0.15 mgxkg-1,). All underwent urological and lower abdominal procedures under bupivacaine 0.5% epidural anesthesia. In the recovery room, mental functions, respiratory and cardiovascular indices were assessed before and after the injection of either flumazenil or saline in a randomized, double-blind manner.
Results:All mental functions were restored by 0.3±0.02 mg flumazenil within 5 min of its administration. Flumazenil-treated patients, arousable by skin stimulation only, were fully awake and calm for the 90 min of the study while the controls remained significantly (P<0.01) more sedated for 60 min. Orientation for time and space improved after flumazenil (scale 0-2, from 0.7±0.1 to 1.9±0.1, P<0.001); fine and coarse coordination became 3 times more accurate than in controls. Amnesia at 5 min was reversed in 44% vs. 8% of control patients (P<0.001). Forced vital capacity (FVC) increased after flumazenil (from 2.1±0.2 to 2.8±0.1 L, P<0.02) and correlated (Pearson correlation coefficient, rp= -0.99) significantly (P = 0.0000) with sedation score. Both younger (40±3 years) and elderly (71±1, P<0.01) patients required a similar dose of flumazenil to restore all functions, and were similar throughout study. Heart rate, blood pressure and respiratory rate did not change following flumazenil administration.
Keywords: discoordination, Flumazenil, Midazolam, sedation, Surgery, Vital Capacity
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Clinical Research
Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical CancerMed Sci Monit In Press; DOI: 10.12659/MSM.945964
Clinical Research
Inflammatory Biomarkers in Smokers: Implications for Ligamentum Flavum HypertrophyMed Sci Monit In Press; DOI: 10.12659/MSM.947508
Clinical Research
Balancing Image Quality and Iodine Intake: Insights from CT Spectral Imaging of the Portal VeinMed Sci Monit In Press; DOI: 10.12659/MSM.947391
Review article
Regulatory Efforts and Health Implications of Energy Drink Consumption by Minors in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.947124
Most Viewed Current Articles
17 Jan 2024 : Review article 7,160,485
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,385
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,806
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 22,071
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912